Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06099197 · ClinicalTrials.gov registry record · NA

I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms in Hispanic Individuals

A NA study of Alzheimer Disease and Caregiver Burden, sponsored by Indiana University.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06099197: Recruiting NA study of Alzheimer Disease and Caregiver Burden, sponsored by Indiana University.

NCT06099197 is a NA study of Alzheimer Disease and Caregiver Burden that is actively recruiting participants, run by Indiana University. The registered enrollment target is 40 participants, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06099197, a NA study of Alzheimer Disease and Caregiver Burden, is actively recruiting participants, sponsored by Indiana University.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This study is a randomized, controlled trial (RCT) to evaluate usability and acceptability, and met and unmet needs from a caregiver intervention app, Brain CareNotes, among unpaid Hispanic caregivers of patients with dementia. Brain CareNotes provides support for management of the behavioral and psychological symptoms of dementia (BPSD) displayed by care recipients. Over 10 months, the trial will enroll 40 Hispanic caregivers of community-dwelling patients diagnosed with Alzheimer's disease or a related dementia (ADRD). Caregivers will be randomized to use the Brain CareNotes app or an attention control education-only app for 12 months, with usage reminders.

Primary Outcome

10-item standardized survey of user-reported technology usability, based on revised System Usability Scale, with scale score computed ranging from 0-100, with 100 indicating highest possible perceived usability.

Interventions

  • BEHAVIORAL Brain CareNotes
  • BEHAVIORAL Dementia Guide Expert

Study Locations (1)

Indiana

  • Indiana University - Bloomington

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2023-09-26
Est. Completion 2026-07
Phase NA
Indiana University

890 total trials

What NCT06099197 shows while recruiting

NCT06099197 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 2 interventions - of which Brain CareNotes is the first listed.

NCT06099197 reports a single indexed study location in Indiana.

Frequently Asked Questions

What is clinical trial NCT06099197 about?

NCT06099197 is a clinical study titled "I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms in Hispanic Individuals". This study is a randomized, controlled trial (RCT) to evaluate usability and acceptability, and met and unmet needs from a caregiver intervention app, Brain CareNotes, among unpaid Hispanic caregivers of patients with dementia. Brain CareNotes provides support for management of the behavioral and ps...

What is the current status of trial NCT06099197?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2023-09-26. Estimated completion is 2026-07.

What conditions does trial NCT06099197 study?

This clinical trial studies the following conditions: Alzheimer Disease, Caregiver Burden.

What interventions are being tested in trial NCT06099197?

The interventions under investigation include: Brain CareNotes (BEHAVIORAL), Dementia Guide Expert (BEHAVIORAL).

Who is sponsoring clinical trial NCT06099197?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06099197 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06099197's enrollment target sits among peer trials

40 221st of 306 higher than 74 of 306 other Alzheimer Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Alzheimer Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06099197, the US trial registry maintained by the National Library of Medicine. NCT06099197 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.